Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Sponsor: Novartis Pharmaceuticals
Summary
A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)
Official title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of LTP001 in Healthy Adult Participants (Part A) and to Evaluate the Efficacy and Safety of LTP001 for the Treatment of Participants With Pulmonary Arterial Hypertension (Part B)
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
232
Start Date
2024-10-24
Completion Date
2028-12-31
Last Updated
2026-03-09
Healthy Volunteers
Yes
Interventions
LTP
LTP001
Placebo
Placebo
Locations (29)
Stanford Medical Center
Stanford, California, United States
Univ Colorado Hospital
Aurora, Colorado, United States
U of Kansas Medical Center
Kansas City, Kansas, United States
Norton Infectious Diseases Specialists
Louisville, Kentucky, United States
Tufts Medical Center
Boston, Massachusetts, United States
Summit Health Eastside Clinic
Bend, Oregon, United States
Statcare Pulmonary Consultants
Knoxville, Tennessee, United States
PPD Development LP
Austin, Texas, United States
The University of Utah
Salt Lake City, Utah, United States
Pul Ass Richmond Inc P A R
Richmond, Virginia, United States
Novartis Investigative Site
Camperdown, New South Wales, Australia
Novartis Investigative Site
Darlinghurst, New South Wales, Australia
Novartis Investigative Site
New Lambton Heights, New South Wales, Australia
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, Brazil
Novartis Investigative Site
Prague, Czechia
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Heidelberg, Germany
Novartis Investigative Site
Thessaloniki, Greece
Novartis Investigative Site
Sassari, SS, Italy
Novartis Investigative Site
Ivrea, TO, Italy
Novartis Investigative Site
Riga, Latvia
Novartis Investigative Site
Almada, Portugal
Novartis Investigative Site
Lisbon, Portugal
Novartis Investigative Site
Bucharest, Romania
Novartis Investigative Site
Toledo, Castille-La Mancha, Spain
Novartis Investigative Site
Las Palmas de Gran C, Las Palmas, Spain
Novartis Investigative Site
Barcelona, Spain
Novartis Investigative Site
Seville, Spain
Novartis Investigative Site
Cambridge, United Kingdom